THC reduced eye pressure by 16%, but only up to a plasma threshold

In 11 healthy adults, inhaled cannabis reduced intraocular pressure by an average of 16% at 60 minutes, with a strong correlation to plasma THC levels up to 20 ng/ml but no further reduction beyond that threshold.

Mosaed, Sameh et al.·Frontiers in medicine·2021·Preliminary EvidenceObservational
RTHC-03364ObservationalPreliminary Evidence2021RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Observational
Evidence
Preliminary Evidence
Sample
N=11

What This Study Found

Peak IOP reduction was 16% at 60 minutes post-inhalation. THC plasma levels correlated strongly with IOP reduction (r = -0.81 for percent reduction) up to 20 ng/ml. Above 20 ng/ml, the correlation disappeared (r = 0.21), suggesting a ceiling effect.

Key Numbers

11 subjects, 22 eyes; peak IOP reduction 16% at 60 min; correlation r = -0.81 below 20 ng/ml; r = 0.21 above 20 ng/ml; change point statistically significant (P < 0.01)

How They Did This

Eleven healthy subjects self-administered a single dose of inhaled cannabis. IOP and plasma THC were measured at baseline, every 30 minutes for the first hour, then hourly for 4 hours. Linear regression and two-line regression models with F-tests identified a change point in the THC-IOP relationship.

Why This Research Matters

Cannabis has long been discussed as a potential glaucoma treatment, but understanding the dose-response relationship is essential. The finding of a ceiling effect at 20 ng/ml plasma THC suggests that higher doses would not provide additional IOP benefit.

The Bigger Picture

The ceiling effect at 20 ng/ml challenges the idea that more THC means more eye pressure reduction. This pharmacological detail is important for anyone considering cannabis-based approaches to IOP management.

What This Study Doesn't Tell Us

Very small sample (11 subjects). Healthy adults only, not glaucoma patients. Single-dose study. Short follow-up of 4 hours. IOP management requires 24-hour control.

Questions This Raises

  • ?Does the ceiling effect persist with chronic use?
  • ?Would the IOP response differ in glaucoma patients?
  • ?Can targeted THC dosing achieve sustained 20 ng/ml plasma levels without psychoactive side effects?

Trust & Context

Key Stat:
16% IOP reduction at peak; ceiling effect at plasma THC 20 ng/ml
Evidence Grade:
Very small pilot study in healthy volunteers with careful pharmacokinetic-pharmacodynamic correlation, but no clinical disease model.
Study Age:
Published in 2021.
Original Title:
The Relationship Between Plasma Tetrahydrocannabinol Levels and Intraocular Pressure in Healthy Adult Subjects.
Published In:
Frontiers in medicine, 8, 736792 (2021)
Database ID:
RTHC-03364

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study

Watches what happens naturally without intervening.

What do these levels mean? →

Frequently Asked Questions

Can cannabis treat glaucoma?

THC does reduce eye pressure, but this study shows the effect plateaus at moderate blood levels. The 4-hour duration is also too short for 24-hour IOP control that glaucoma requires.

Does more THC mean more eye pressure reduction?

Only up to a point. Above plasma levels of 20 ng/ml, additional THC did not produce further IOP reduction in this study.

Read More on RethinkTHC

Cite This Study

RTHC-03364·https://rethinkthc.com/research/RTHC-03364

APA

Mosaed, Sameh; Smith, Andrew K; Liu, John H K; Minckler, Donald S; Fitzgerald, Robert L; Grelotti, David; Sones, Emily; Weinreb, Robert N; Marcotte, Thomas D. (2021). The Relationship Between Plasma Tetrahydrocannabinol Levels and Intraocular Pressure in Healthy Adult Subjects.. Frontiers in medicine, 8, 736792. https://doi.org/10.3389/fmed.2021.736792

MLA

Mosaed, Sameh, et al. "The Relationship Between Plasma Tetrahydrocannabinol Levels and Intraocular Pressure in Healthy Adult Subjects.." Frontiers in medicine, 2021. https://doi.org/10.3389/fmed.2021.736792

RethinkTHC

RethinkTHC Research Database. "The Relationship Between Plasma Tetrahydrocannabinol Levels ..." RTHC-03364. Retrieved from https://rethinkthc.com/research/mosaed-2021-the-relationship-between-plasma

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.